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Abstract
Chronic/abnormal activation of endoplasmic reticulum (ER) stress is linked to the exacerba-
tion of the inflammatory process and has been recently linked to Crohn’s disease (CD)
pathophysiology. We investigated the intestinal mucosa and the mesenteric adipose tissue
(MAT) collected from CD patients with active disease (CD group) and from non-IBD patients
(CTR group) to study ER stress activation and to address tissue-specific modulation in CD.
The intestinal mucosa of CD patients showed an upregulation in the expression of ER stress
related genes, including ATF3, DNAJC3, STC2, DDIT3, CALR, HSPA5 and HSP90B1.
Results showed that EIF2AK3 gene was upregulated, along with increased protein ex-
pression of p-eIF2α and p-eIF2α/eIF2α ratio. Additionally, ERN1 gene expression was upre-
gulated, along with an increased spliced/activated form sXBP1 protein. Despite the
upregulation of ATF6 gene expression in the intestinal mucosa of CD patients, no differ-
ences were found in ATF6 protein expression. Lastly, the analysis of MAT revealed
unchanged levels of ER stress markers along with no differences in the activation of UPR.
However, chaperone gene expression was modulated in the MAT of CD patients. To con-
clude, our results address tissue-specific differences in UPR activation in CD and point the
ER stress as an important pro-inflammatory mechanism in CD, specifically in the intestinal
mucosa.







Citation: Coope A, Pascoal LB, Botezelli JD, da
Silva FAR, Ayrizono MdLS, Rodrigues BL, et al.
(2019) ER stress activation in the intestinal mucosa
but not in mesenteric adipose tissue is associated
with inflammation in Crohn’s disease patients.
PLoS ONE 14(9): e0223105. https://doi.org/
10.1371/journal.pone.0223105
Editor: Arun Rishi, Wayne State University,
UNITED STATES
Received: May 31, 2019
Accepted: September 12, 2019
Published: September 26, 2019
Copyright: © 2019 Coope et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the manuscript and its Supporting
Information files.
Funding: Financial support was received by:
FAPESP (São Paulo Research Foundation) [Grant
number 2016/01638-7 for R.F.L.]; CNPq (National
Council for Scientific and Technological
Development) [Grant number 401270/2016-5 for
R.F.L.]. A.C. received Post-doctoral scholarship
from CAPES (Coordination for the Improvement of
Introduction
Crohn’s Disease (CD) is a chronic multifactorial inflammatory bowel disease (IBD) character-
ized by transmural granulomatous inflammation, mucosal immune cell activation, abnormal
immune response and cytokine imbalance, due to a complex interaction encompassing genetic
predisposition, environmental risk factor, microbiota dysregulation and impaired mucosal
immune system [1,2]. The inflammatory transcriptional profile in CD is different and complex
throughout the tissues. A study conducted by our group demonstrated for the first time that
the mesenteric adipose tissue (MAT) of CD patients shows an increased activation of the
STAT1 (Signal transducer and activator of transcription 1) pathway, along with an increase of
the anti-inflammatory IL-10 (Interleukin-10) cytokine, and decreased activation of IκB (inhib-
itor of kappa B). Additionally, reinforces the predominance of the pro-inflammatory NF-κB
(nuclear factor kappa B) activation in the intestinal mucosa with increased TNF-α (Tumor
necrosis factor-α), IL-1β (Interleukin-1β) and IL-23 (Interleukin-23) activation [3]. However,
the MAT of CD patients shows an impaired autophagy and apoptosis regulation [4,5],
which display the complex interplay between intestinal mucosa and MAT in the pathogenesis
of CD and highlights the importance of dissecting the molecular mechanisms that drive
inflammation.
Recent studies have implicated the activation of ER stress in the pathogenesis of IBD, as it
contributes to the perpetuation of the inflammatory process and autoimmunity [6,7]. Aber-
rant/inadequate UPR response contributes to the development of autoimmune diseases by cre-
ating disturbances in immune and non-immune cells [7]. The ER is an important organelle in
eukaryotic cells responsible for biosynthesis, folding, assembly and modification of membrane
and secretory proteins. Nearly one-third of all proteins are processed in the ER. A number of
stressor factors, like microbial pathogens, radiation, hypoxia, nutrient deprivation, toxins,
among other environmental stressors, can cause accumulation of misfolded or unfolded pro-
teins in the ER during protein synthesis, leading to ER stress. Interestingly, eukaryotic cells
have evolved a mechanism to cope with the increased protein cargo, to ensure the fidelity of
protein folding, and to reach homeostasis known as the unfolded-protein response (UPR) [8].
Three UPR axis are activated in response to ER stress: IRE1/sXBP1 (inositol requiring enzyme
1/spliced form of X-box binding protein-1), ATF6 (activating transcription factor 6) and
PERK/eIF2α (PKR-like eukaryotic initiation factor 2α kinase/ eukaryotic translation initiation
factor 2 α). Together, they coordinate a response to the unfolded/misfolded proteins
accumulation.
Other key components of the UPR response are the chaperones, such as 78-glucose regu-
lated protein (GRP78/BiP) [8,9] and 94-glucose regulated protein (GRP94, gp96, endoplasmin,
Erp99, HSP108 or Tra-1) [10,11]. Normal UPR response is important for the development,
survival and function of secretory cells like immunoglobulin-producing plasma cells, survival
and function of dendritic cells and macrophages, in addition to maintenance of normal epithe-
lial function [6,7].
The host’s ability to deal with the ER stress is possibly involved in the pathogenesis of intes-
tinal inflammation. ER stress-induced inflammation is an important protective response for
the organism’s function and survival. However, it becomes detrimental when chronically
engaged [8,12,13]. The UPR is needed to activate the inflammatory response through a variety
of inflammatory signaling pathways including IκB kinase (IKK)/NF-κB and c-Jun N-terminal
Kinase (JNK)/AP1. IRE1α activates JNK/AP1 pathway triggering upregulation of inflamma-
tory genes [14]. Interestingly, IRE1α, PERK and ATF6 activates IKK/NF-κB through multiple
and distinct mechanisms [15–18]. Chronic UPR activation leads to exacerbation of the inflam-
matory process and can ultimately result in cellular apoptosis triggering cellular and tissue
ER stress activation in Crohn’s disease patients
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damage [8]. Thus, abnormal/chronic ER stress activation can contribute to the upregulation of
intestinal inflammatory pathways observed in CD patients [6,12,13]. Therefore, evaluating the
transcriptional and protein levels of UPR components is an accurate way of studying ER stress,
as well as detecting whether chronic damage is already occurring as a result of increased apo-
ptosis pathway activation [8,19,20].
In this study, we investigated the activation of the three UPR branches in the intestinal
mucosa and in the MAT of CD and control patients, and showed for the first time in the litera-
ture, the tissue-specific differences of ER stress activation in CD patients, which is important
for addressing tissue-specific drug response and new drug development in the field.
Material and methods
Patients and ethics statement
Samples from intestinal mucosa and MAT, located near the affected intestinal area, were taken
from patients with ileocecal CD (CD Group) after surgical resection. The control groups were
composed of patients who underwent intestinal resection for non-inflammatory disease, with
normal distal ileum (MAT biopsies near the ileum were collected during the surgery—CTR
group of MAT) and patients with normal ileocolonoscopy (mucosa biopsies were taken—CTR
group of intestinal mucosa). The intestinal mucosa control group was composed by individu-
als who underwent colonoscopy for surveillance of colorectal cancer or investigation of bleed-
ing, without macroscopic abnormalities after examination. Afterwards, histological analysis
(Haematoxylin & Eosin, H&E) was performed to confirm the normal findings of the
colonoscopy.
Concerning the CD group, disease activity was assessed by colonoscopy before surgery and
all patients had more than 250 points in the Crohn’s disease activity index (CDAI). Table 1
shows the clinical and demographic characteristics of patients included in the study. We
selected CD patients with distal ileal involvement because this is the most common anatomical
site of disease affection. All patients included in the study had an albumin level higher than
3mg/dL prior to the surgical procedure, which is important to decrease the complication rates
after surgery. Malnourished patients received nutritional support before surgery. Sample col-
lection was performed when all patients were nourished and had a reasonable nutritional con-
dition. Body mass index (BMI) was below 25, which excluded obesity as a risk factor.
Moreover, the CD patients fasted prior to surgery (12 hours), as did the control subjects who
underwent colonoscopy, thus excluding this variable from the study.
In this exploratory observational study, a formal sample size calculation was not performed.
The study was conducted in accordance with the Declaration of Helsinki and approved by the
Ethics Committee of the University of Campinas (n˚ 356/2009 and CAAE n˚ 0271.0.146.000–
09). All participants read and signed a written informed consent form for study participation.
The study was carried out at the IBD Research Laboratory and the Laboratory of Cell Signaling
of the School of Medical Sciences, University of Campinas (UNICAMP).
Western blot analysis
For total protein extract preparation, the fragments of intestinal and MAT were previously
snap-frozen and stored at—80˚C. They were homogenized in approximately 10 volumes of
solubilization buffer containing 1% Triton X-100, 100 mM Tris (pH 7.4), 100 mM sodium
pyrophosphate, 100 mM sodium fluoride, 10 mM EDTA, 10 mM sodium orthovanadate, 2
mM PMSF (phenylmethylsulfonyl fluoride) and 0.1 mg/mL aprotinin at 4˚C in a “Polytron
PTA 20S Generator” (model PT 10/35; Brinkmann Instruments, Westbury, NY). Insoluble
material was removed by centrifugation (40 min at 12000 rpm at 4˚C). Protein concentrations
ER stress activation in Crohn’s disease patients
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were determined using the Pierce™ BCA Protein Assay Kit (Thermo, NY, USA). A 50 μg ali-
quots were separated by SDS-PAGE, transferred to nitrocellulose membranes, and blotted
with specific antibodies. Reagents for SDS-PAGE and immunoblotting were from BioRad Lab-
oratories (Richmond, CA). Phenylmethylsulfonyl fluoride, aprotinin, Triton X-100, Tween 20,
and glycerol were from Sigma (St. Louis, MO). Nitrocellulose paper (BA85, 0.2 mm) came
from Amersham (Aylesbury, UK). Molecular weights of proteins were assessed using the
PageRulerTM from Fermentas (Glenburnie, MD). Ponceau S staining was applied to deter-
mine the loading control and protein transfer efficiency as described by Fortes et al [21] and
by Romero-Calvo et al [22]. In summary, immediately after the wet transfer, membranes were
washed for five minutes in deionized water to remove the transfer buffer. The membranes
were washed in Ponceau S staining (5%) for 5 minutes. The solution was removed, and mem-
branes were washed for 5 minutes in deionized water to remove the background. After this
Table 1. Clinical and demographic characteristics of the patients included in the study for the qRT-PCR analysis.
Patients included in the qPCR analysis




Number 10 8 8
Gender (M/F) 4/6 3/5 5/3
Age (years) 32.5 [20–66] 56 [33–66] 54.5 [39–67]
Disease duration (years) 6 [1–20] - -
Age at diagnosis (A1/A2/A3)� 1/7/2 - -
Location (L1/L2/L3/L4)� 4/0/6/0 - -
Behaviour (B1/B2/B3)� 0/4/6 - -
Perianal disease (yes/no) 2/8 - -
Immunosuppressant (yes/no) 7/3 - -
Anti-TNFα (yes/no) 10/0 - -
CDAI 321 [261.4–609.6] - -
Presence of ulcers (yes/no)�� 10/0 0/10 0/10
Patients included in the Western Blot analysis
CD Group Control Group
(intestinal mucosa)
-
Number 19 7 -
Gender (M/F) 7/12 2/5 -
Age (years) 37 [20–70] 56 [44–69] -
Disease duration (years) 6 [1–30] - -
Age at diagnosis (A1/A2/A3)� 1/15/3 - -
Location (L1/L2/L3/L4)� 6/0/13/0 - -
Behaviour (B1/B2/B3)� 0/11/8 - -
Perianal disease (yes/no) 2/17 - -
Immunosuppressant (yes/no) 7/12 - -
Anti-TNFα (yes/no) 14/5 - -
CDAI 302.5 [162–428] - -
Presence of ulcers (yes/no)�� 19/0 0/7 -
Numerical variables are described as median [min, max] and categorical variables as absolute frequencies.
�Montreal Classification.
��Presence of ulcers in the ileum evaluated by colonoscopy examination.
CD = Crohn’s disease. MAT = mesenteric adipose tissue. M = male. F = female. TNF = tumor necrosis factor. CDAI = Crohn’s disease Activity Index.
https://doi.org/10.1371/journal.pone.0223105.t001
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process, the membranes were scanned and converted to black and white images. Using optical
densitometry (UN-SCAN-IT gel), lanes were selected and the total pixels in each lane was used
as loading control (S1 Fig). The electrophoretic gels and blots, and the compliance with the
digital images are shown in S1 Appendix.
The antibodies, anti-eIF2α (sc11386, rabbit polyclonal) was purchased from Santa Cruz
Biotechnology (CA, USA) and anti-phosphor-[Ser51] eIF2α (ab32157, rabbit monoclonal)
were purchased from Abcam; anti-ATF6 (Fulllength and Active/Cleaved Forms. Clone
70B1413.1 IMG-273, mouse monoclonal) was purchased from Imgenex and purified anti-
Xbp-1 (COOH terminus) (619502, rabbit polyclonal) was purchased from BioLegend. The sig-
nal was detected by a chemiluminescent reaction (SuperSignal West Pico Chemiluminescent
Substrate from Pierce Biothecnology, Inc. Rockford, IL) and quantified by optical densitome-
try (UN-SCAN-IT gel).
RNA extraction and cDNA synthesis
Total RNA was extracted using the RNeasy Mini Kit (Qiagen—Cat No./ID: 74104), according
to the manufacturer’s instructions. RNA purity and concentration were determined by UV
spectrophotometry at 260 nm. For cDNA synthesis, we used the High Capacity cDNA Reverse
Transcription Kit (Applied Biosystems, Foster City, CA, USA), according to the manufactur-
er’s instructions. The cDNA was diluted to the concentration required for the efficient amplifi-
cation of each gene.
Quantitative real-time PCR (qPCR)
Real-time quantitative PCR reactions were performed using the TaqMan ™ system (Applied
Biosystems). Taqman Primers used was: EIF2AK3 (Hs_00178128_m1), ATF3 (Hs_00231069_
m1), ATF6 (Hs_00232586_m1), calreticulin (Hs_00189032_m1), STC2 (Hs_00175027_m1),
DNAJC3 (Hs_00534483_m1), DDIT3 (Hs_00358796_g1), ERN1 (Hs_00980095_m1), HSPA5
(Hs_99999174_m1), HSP90B1 (Hs_00427665_g1), and glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) (4326317E) were obtained from Applied Biosystems. The Taqman primer:
DEFA5A (NM_021010) was obtained from Integrated DNA Technologies (IDT). All measure-
ments were normalized by the expression of GAPDH gene, which is generally considered a sta-
ble housekeeping gene. Life Technologies follows the pattern of assigning FAM™ dye as the
reporter for the target assay and assigning VIC1 dye as the reporter for the normalizer assay.
RT-PCR was performed on resulting cDNA, using the manufacturer’s protocol. RT-PCR
amplification consisted of an initial denaturation step 45 cycles of denaturation (95˚C for 3
min), annealing (95˚C for 5 s) and extension (60˚C for 30 s), followed by a final incubation at
60˚C for 1 minute. Each PCR contained 40 ng of reverse-transcribed RNA, 2.5 μl of each spe-
cific primer, Taqman Universal master mix (4369016, Life Technologies) and RNAse-free
water at a final volume of 10 μl. Real-time PCR analysis of gene expression was carried out on
the Applied Biosystem StepOneTM detection system. Gene expression was determined using
the delta-delta Ct method.
Hematoxylin and eosin (H&E) staining
Paraffin-embedded ileal and MAT blocks of 10 CD patients and 8 controls were cut at 5 μm
and used for histological analysis. Sections were stained with H&E dye. Photomicrographs
were recorded using the Leica DM4500microscope and the Leica DFC290 digital camera for
microscopy with control software (Leica Microsystems, Wetzlar).
ER stress activation in Crohn’s disease patients
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PAS-Alcian blue staining
Paraffin-embedded ileal blocks of one CD patient and one control were cut at 5 μm and used
for histological analysis. Sections were stained with PAS-Alcian Blue dye. Photomicrographs
were recorded using the Leica DM4500microscope and the Leica DFC290 digital camera for
microscopy with control software (Leica Microsystems, Wetzlar).
Immunohistochemistry (IHC)
Paraffin-embedded ileal blocks of two patients from each group (CTR and CD groups) were cut
at 5 μm and used to investigate the localization of specific proteins. The slides preparation
included deparaffinization, hydration, followed by antigen retrieval and staining. Antigen
retrieval was performed using a citrate buffer solution (10 mM, pH 6.0) for 30 minutes at 95˚C.
The endogenous peroxidase was blocked performing 3 washes of 10 minutes each using a block-
ing solution based on hydrogen peroxide (3% H2O2 10 vol), followed by washes in distilled
water and phosphate buffered saline (PBS, 10 mM, pH 7.4). The primary antibodies were
diluted in predetermined titter in a 1% bovine serum albumin (BSA) in PBS buffer and incu-
bated overnight at 4˚C. The antibodies employed were: GRP78 (sc13968, rabbit polyclonal),
GRP94 (sc11402, rabbit polyclonal) purchased from Santa Cruz Biotechnology; anti-phosphor-
[Ser51] eIF2α (ab32157, rabbit monoclonal) purchased from Abcam; purified anti-Xbp-1
(COOH terminus) (619502, rabbit polyclonal) purchased from BioLegend; PE Mouse Anti-
Human CD45 (555483) purchased from BD Pharmingen; and Lysozyme (RB-372-A1, rabbit
polyclonal) purchased from Thermo Scientific. For detection we washed the slides with PBS
and incubated for 30 minutes with AdvanceTM HRP Link (DAKO, K4068) followed by washes
in PBS buffer and incubation with Advance HRP Enzyme for 30 min. The slides were washed
in PBS and incubated with DAB solution (1 drop of the DAB Chromogen per 1 mL of Substrate
Buffer) (DAKO, K3468). The slides were rinsed with distilled water and counterstained with
Mayer’s Hematoxylin, followed by immersion on 0.037 mol/L ammonia solution. The slides
were washed, dehydrated and mounted with Entellan1New (Cat. no. 107961—Merck, Ger-
many). Photomicrographs were recorded using the Leica DM4500microscope and the Leica
DFC290 digital camera for microscopy with control software (Leica Microsystems, Wetzlar).
Statistical analysis
All results are reported as median with interquartile range. Test for distributional adequacy,
the Kolmogorov-Smirnov test was used to investigate if the data follow normal distribution or
Gaussian distribution (p>0.1). Data were analyzed using the non-parametric Mann-Whitney
Test. The level of significance was set at p<0.05. (S1 Table)
Ethics approval and consent to participate
This study was approved by the Ethics Committee of the University of Campinas (UNI-
CAMP), all patients signed the informed consent form, and were performed in accordance
with the Declaration of Helsinki.
Results
IRE1/sXBP-1 pathway is activated in the intestinal mucosa, but not in
MAT of Crohn’s disease patients
We started this investigation by analyzing the inflammatory status and morphometric parame-
ters of the intestinal mucosa and MAT in CD patients and controls. Histological analysis using
ER stress activation in Crohn’s disease patients
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H&E staining showed crypt distortion and thickening of the bowel associated with inflamma-
tion in the intestinal mucosa of CD patients, compared to the control group. H&E staining in
MAT of CD patients showed a reduced adipocyte area and perimeter compared to the control
group (S2A Fig). The CD45 staining by immunohistochemistry revealed infiltrating immune
cells in the intestinal mucosa and MAT from CD and control groups (S2B Fig).
To better evaluate the ER stress activation, we dissected the UPR branches by qPCR, immu-
noblotting and immunohistochemistry in CD and CTR samples. IRE1/sXBP1 was the first
UPR axis investigated. ERN1, which encodes IRE1 protein, is upregulated in the intestinal
mucosa (Fig 1A), but is not modulated in the MAT of CD patients compared to respective
controls (Fig 1B). Since the measurement of sXBP1 is an accurate form to infer the activation
of IRE1 pathway, we investigated the protein expression of sXBP1 using an antibody that spe-
cifically recognizes the spliced variant of XBP1. The increased gene expression of ERN1 is in
line with the increased protein expression of the active sXBP1 in the intestinal mucosa of CD
patients (Fig 1C), which implies the activation of this UPR branch. The localization of sXBP1
in the intestinal mucosa was investigated by immunohistochemistry. The immunoreactivity of
sXBP1 protein is present in the apex of intestinal villi of the CD group, while it was evident in
the intestinal crypt base in the control group. Immunostaining also revealed sXBP1 expression
in the immune cells in the lamina propria in both groups (Fig 1D).
ATF6 pathway is not activated in the intestinal mucosa and MAT of
Crohn’s disease patients
The second UPR axis investigated was the ATF6 pathway. We observed an upregulation of
ATF6 transcriptional levels in the intestinal mucosa of CD patients (Fig 2A). Furthermore, it
remained unchanged in the MAT when compared to respective controls (Fig 2B). Despite the
changes in ATF6 gene expression in intestinal mucosa, no differences were found in ATF6
protein levels in both groups (Fig 2C).
PERK/eif2α pathway is activated in the intestinal mucosa, but not in MAT
of Crohn’s disease patients
The third UPR axis investigated was the PERK/eIF2α pathway. The EIF2AK3, that encodes the
PERK protein, showed an upregulation in the intestinal mucosa (Fig 3A) of CD patients. Con-
versely, no differences were found in the MAT compared to the respective controls (Fig 3B).
The increased expression of PERK in intestinal mucosa corroborates a significant increase of
both the p-eIF2α protein levels and the p-eIF2α/eIF2α ratio (Fig 3C). Therefore, we observed
the activation of PERK pathway in the intestinal mucosa of CD patients. Additionally, we
investigated the location of p-eIF2α in the intestinal mucosa of CD patients by immunohis-
tochemistry and verified the p-eIF2α immunoreactivity in the base of intestinal crypts, in the
apex of intestinal villi and in the immune cells from the lamina propria in both groups (Fig
3D).
Transcriptional evaluation of genes responsive to the UPR pathways
implies the ER stress activation in intestinal mucosa, but not in MAT of
Crohn’s disease patients
We evaluated the transcriptional levels of several ER stress responsive genes in biopsies of two
different tissues: intestinal mucosa and MAT of CD patients and respective controls. We dem-
onstrate an upregulation of the activating transcription factor 3 (ATF3) (Fig 4A), the calcium-
regulatory protein stanniocalcin-2 (Fig 4B), and the DDIT3 (CHOP) (Fig 4C) in the intestinal
ER stress activation in Crohn’s disease patients
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Fig 1. Activation of IRE1/sXBP1 pathway in the intestinal mucosa and in the mesenteric adipose tissue (MAT) of Crohn’s disease
patients. mRNA levels (qRT-PCR) of ERN1 gene was investigated in the intestinal mucosa (A) and in MAT (B) of CD patients (CD group)
compared to control group (CTR group).�P< 0.05 and ��p< 0.01 are considered statistically significant versus control group. Western blot
ER stress activation in Crohn’s disease patients
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mucosa of CD patients by Real-Time PCR. Additionally, the transcriptional levels of ATF3,
stanniocalcin-2 and DDIT3 remained unchanged in the MAT of CD patients (Fig 4D, 4E and
4F respectively).
analysis of the spliced/activated form of XBP1 was evaluated in the intestinal mucosa of CD patients (CD Group) compared to controls
(CTR Group) (C). Each band represents one patient. �P< 0.05 and ��p< 0.01 are considered statistically significant versus control group.
Immunohistochemical analysis of sXBP1 was performed on paraffin-embedded slides from intestinal mucosa of CD and CTR group. The
arrows show labeled epithelial cells by immunohistochemistry. Original magnification 100X (D). AU: arbitrary unit. ASU: arbitrary
scanning unit.
https://doi.org/10.1371/journal.pone.0223105.g001
Fig 2. Activation of ATF6 pathway in the intestinal mucosa and in the mesenteric adipose tissue (MAT) of Crohn’s disease
patients. mRNA levels (qRT-PCR) of ATF6 gene was investigated in the intestinal mucosa (A) and in MAT (B) of CD patients (CD
group) compared to control group (CTR group). Western blot analysis of the cleaved form of ATF6 protein was evaluated in the
intestinal mucosa of CD patients (CD Group) compared to controls (CTR Group) (C). Each band represents one patient. �p< 0.05 and
��p< 0.01 are considered statistically significant versus control group. AU: arbitrary unit. ASU: arbitrary scanning unit.
https://doi.org/10.1371/journal.pone.0223105.g002
ER stress activation in Crohn’s disease patients
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Fig 3. Activation of PERK/eIF2α pathway in the intestinal mucosa and in the mesenteric adipose tissue (MAT) of Crohn’s disease patients. mRNA levels
(qRT-PCR) of EIF2AK3 gene was investigated in the intestinal mucosa (A) and in MAT (B) of CD patients (CD group) compared to control group (CTR group).
�p< 0.05 and ��p< 0.01 are considered statistically significant versus control group. Western blot analysis of phosphorylated and total form of the protein eIF2α (C),
was evaluated in the intestinal mucosa of CD patients (CD Group) compared to controls (CTR Group). Each band represents one patient. �p< 0.05 and ��p< 0.01 are
considered statistically significant versus control group. Immunohistochemical analysis of p-eIF2α was performed on paraffin-embedded slides from intestinal mucosa
of CD and CTR group. The arrows show labeled epithelial cells by immunohistochemistry. Original magnification 100X (D). AU: arbitrary unit. ASU: arbitrary
scanning unit.
https://doi.org/10.1371/journal.pone.0223105.g003
ER stress activation in Crohn’s disease patients
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Chaperones modulation in the intestinal mucosa and MAT of Crohn’s
disease patients
In the last step of this study, we investigated the modulation of chaperones in CD. The activa-
tion of UPR branches leads to increased production of chaperones, so this is a broadly used ER
stress marker. The intestinal mucosa of CD patients showed an upregulation of the co-chaper-
one DNAJC3 (Fig 5A), theHSPA5 gene that encodes GRP78/BiP protein (Fig 5B), the
HSP90B1 gene that encodes GRP94 (Fig 5C) and the CALR gene that encodes the chaperone
calreticulin (Fig 5D), corroborating our previous results of ER stress activation in the intestinal
mucosa of CD patients. Despite the absence of changes in the co-chaperone DNAJC3 (Fig 5E),
theHSPA5 gene expression was decreased in the MAT of CD compared to control group (Fig
5F). Interestingly, the transcriptional levels ofHSP90B1 (Fig 5G) and CALR (Fig 5H) were
increased in MAT of CD patients. Thus, the decrease inHSPA5 along with increased expres-
sion ofHSP90B1 and CALR establish a chaperone modulation in the MAT even without
ER stress activation. Additionally, we performed immunohistochemistry to investigate the
chaperones’ localization in the intestinal mucosa. We observed the GRP78 and the GRP94
Fig 4. Activation of ER stress responsive genes in the intestinal mucosa and mesenteric adipose tissue (MAT) of Crohn’s disease patients. mRNA levels (qRT-PCR)
of ATF3 (A), STC2 (B) andDDIT3 (C) were investigated in intestinal mucosa of CD patients (CD Group) compared to controls (CTR Group). mRNA levels (qRT-PCR)
of ATF3 (D), STC2 (E) andDDIT3 (F) were evaluated in MAT of CD patients (CD Group) compared to controls (CTR Group). �p< 0.05 and ��p< 0.01 are considered
statistically significant versus control group. AU: arbitrary unit.
https://doi.org/10.1371/journal.pone.0223105.g004
ER stress activation in Crohn’s disease patients
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Fig 5. Chaperones and co-chaperone expression in the intestinal mucosa and in the mesenteric adipose tissue (MAT) of Crohn’s disease patients. mRNA levels
(qRT-PCR) of DNAJC3 (A),HSPA5 (B),HSP90B1 (C) and CALR (D) genes were investigated in the intestinal mucosa of CD patients (CD group) compared to control
group (CTR group). mRNA levels ofDNAJC3 (E),HSPA5 (F),HSP90B1 (G) and CALR (H) genes were also investigated in the MAT of CD and CTR group. �p< 0.05
and ��p< 0.01 are considered statistically significant versus control group. Immunohistochemical analysis of GRP78 (I) and GRP94 (J) were performed on paraffin-
embedded slides from intestinal mucosa of CD and CTR group. The arrows show labeled epithelial cells by immunohistochemistry. Original magnification 100X. AU:
arbitrary unit.
https://doi.org/10.1371/journal.pone.0223105.g005
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immunoreactivities in the apex of the intestinal epithelial villi, in the base of intestinal crypts
and in the immune cells from the lamina propria of both control and CD groups (Fig 5I and
5J).
To better investigate the ER stress activation in the intestinal crypts, we performed immu-
nohistochemistry for lysozyme and PAS-Alcian Blue, which identify Paneth cells and acidic
sulphated mucins respectively. We verified lysozyme, GRP78 and p-eIF2α positive cells at the
base of the crypts that are consistent with the localization of Paneth cells in the intestinal epi-
thelium of control and CD groups (Fig 6). For quantitative analysis, we investigate the tran-
scription profile of α-defensin 5 encoded by the gene DEFA5. The α-defensins are specifically
secreted by Paneth cells localized in the base of the intestinal crypts [23]. Our results showed
no differences on DEFA5 gene expression compared to control group (S3 Fig).
Discussion
Genetic alterations of ER stress related-genes associate with IBD, specifically in CD and ulcera-
tive colitis (UC) patients [12,24]. Experimental studies point towards ER stress activation as a
new pathway driving intestinal inflammation, as demonstrated by XBP1 deletion in intestinal
epithelial cells leading to activation of ER stress and spontaneous enteritis [12,25]. The molecu-
lar mechanisms that trigger inflammation in CD differ between the intestinal mucosa and the
hypertrophied MAT near the affected intestinal area [3,26]. In the present study, we addressed
tissue-specific molecular mechanisms of ER stress in the intestinal mucosa and MAT of CD
patients that play a role in CD inflammation.
We initiated the study investigating the three UPR axis activated upon ER stress. The first
UPR branch analyzed was IRE1/sXBP1. IRE1α activates c-Jun N-terminal Kinase (JNK)/AP1
pathway and NF-κB, triggering upregulation of inflammatory genes, and contributes to the
inflammation and stress-induced cell death [2,14,27]. In fact, our group previously demon-
strated increased NF-кB activation in the ileum of CD patients [3]. We observed an increased
expression of the ERN1 transcriptional levels, which induced the spliced form of XBP1 protein
in the intestinal mucosa of CD patients. In CD, the epithelial damage of the intestinal mucosa
occurs mainly in the apex of the villi, along with increased apoptosis [28], which corroborates
our findings of sXBP1 immunoreactivity distribution. Conversely, no differences on ER stress
activation were observed in the MAT of CD patients, which suggests the absence of NF-кB
activation in this tissue [3].
The second UPR branch evaluated in the intestinal mucosa and in MAT of CD was the
ATF6. ATF6 acts in parallel with IRE1 pathway to induce chaperone expression and other ele-
ments to increase protein folding, and ERAD components. Our results demonstrate an
increased expression of ATF6 gene in the intestinal mucosa of CD patients, without any con-
current activation in MAT as compared to control group. Interestingly, the increase in ATF6
transcriptional level does not translate into an augmentation of the activated/cleaved form of
ATF6 protein in the intestinal mucosa of CD patients, suggesting no involvement of this UPR
axis in CD. The third UPR branch investigated was the PERK/eIF2α pathway. Our results
showed increased EIF2AK3 gene expression, responsible for encoding PERK protein. Addi-
tionally, we observed increased p-eIF2α protein content and p-eIF2α/eIF2α ratio in the intesti-
nal mucosa of CD patients, which implies the activation of this UPR axis in CD. Furthermore,
we show the p-eIF2α immunoreactivity at the base of the crypts that are consistent with the
localization of Paneth cells and at the apex of intestinal villi in both groups. Conversely, no
activation occurred in MAT when compared to the control group.
Moreover, in this study we addressed the differences of ER stress-related genes in the intes-
tinal mucosa and MAT of CD patients compared to control group. The expression of the
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transcriptional regulator ATF3 occurs early in response to ER stress by p-eIF2α and subse-
quently ATF4. Along with ATF4, ATF3 engage a transcriptional cascade to initiate apoptosis
through activation of CHOP (also known as GADD153 or DDIT3) [29]. Our results show an
upregulation of ATF3 expression in the intestinal mucosa of CD patients, with no differences
in MAT as compared to control groups. STC2 gene, responsible for encoding the secreted gly-
coprotein stanniocalcin 2, which is induced by ATF4 upon ER stress and plays a role in cal-
cium influx and calcium homeostasis in the cell. Stanniocalcin 2 acts as a pro-survival protein
participating in the negative feedback of p-eIF2α and ATF4 [30–32]. Here we show an increase
in STC2 gene expression in the intestinal mucosa of CD patients, with no activation in the
MAT compared to control patients.
Another ER stress-related gene investigated in this study was DNA Damage-Inducible Tran-
script 3 (DDIT3), responsible for encoding the pro-apoptotic CHOP protein. Our results dem-
onstrated an upregulation of DDIT3 gene expression in the intestinal mucosa of CD patients
that suggests an increased cell death in this tissue. Thus, CHOP activation observed in the
intestinal mucosa of CD patients could be due to the activation of both UPR branches: IRE1
and PERK/eIF2α. As expected, no differences in CHOP activation were observed in the MAT
of CD patients.
Moreover, we investigated the modulation of chaperones and co-chaperone in CD. Initially
we evaluated the gene expression of DNAJC3 that encodes the J-domain co-chaperone
DNAJC3. The ER stress induces the expression p58/DNAJC3, which acts as the GRP78 co-
chaperone buffering the load of unfolded/misfolded protein in the ER and preventing chronic
UPR activation and cell apoptosis [33,34]. Our results demonstrate an increased expression of
DNAJC3 gene in the intestinal mucosa of CD patients, with no activation in MAT compared
to control group.
In this study, we also investigated the expression ofHSPA5 gene responsible to encode the
GRP78/BiP protein in CD. Upon stress, GRP78/BiP can be reallocated in the cell, where it per-
forms different functions related to signaling, proliferation, apoptosis and inflammation
[10,35–37]. An interesting study demonstrates the role of TNFα-induced inflammation in the
reallocation of GRP78/BiP to the cytoplasm of epithelial cells in IBD. Cytoplasmic GRP78/BiP
interacts directly with IKK complex and activates the NFκB signaling [13]. Here, we show an
upregulation ofHSPA5 gene in the intestinal mucosa of CD patients compared to the control
group. In addition, the immunohistochemistry analysis showed GRP78 immunoreactivity in
the base of intestinal crypts consistent with the localization of Paneth cells. Interestingly, in the
MAT of CD patients we demonstrate a decreased expression ofHSPA5 gene compared to the
control group. TheHSPA5 downregulation in MAT needs further investigation, but could be
due to the activation of STAT1 pathway and increased expression of IL-10 cytokine observed
in the MAT of CD patients [3].
Key chaperones in the ER, along with GRP78/BiP, include the heat shock protein GRP94,
encoded byHSP90B1 gene, and the glycoprotein-associated chaperone calreticulin, encoded
by CALR gene. In our study we demonstrated an upregulation ofHSP90B1 and CALR in the
intestinal mucosa and MAT of CD patients. The chaperone upregulation is a common feature
in UPR response, so this result corroborates with ER stress activation in the intestinal mucosa
in CD. Interestingly, in order to maintain the quality control in the ER, a decrease expression
or depletion of one chaperone affect the activity and expression of other chaperones.
Fig 6. Intestinal crypt characterization of Crohn’s disease (CD) patients and controls. Immunohistochemical analysis of GRP78 and
p-eIF2α were performed on paraffin-embedded slides from intestinal mucosa of CD and CTR group. Lysozyme immunohistochemical
staining identifies Paneth cells. PAS-Alcian Blue staining reveals cells with mucus. Positive cells for GRP78, p-eIF2-α and lysozyme are
shown in brown. Positive cells for PAS-Alcian Blue are shown in light blue. Original magnification 1000X.
https://doi.org/10.1371/journal.pone.0223105.g006
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Specifically, the decreased expression of GRP78 is known to induce upregulation of the chap-
erones GRP94, calreticulin, PDI and Erp57 [38,39]. Thus, the increased expression of the chap-
erones GRP94 and calreticulin in the MAT of CD patients may be a compensatory mechanism
in response to the downregulation of GRP78 observed in this tissue. Further studies are impor-
tant to understand the regulatory mechanism of upregulation of GRP94 and calreticulin due
to decreased GRP78 in the MAT of CD patients.
Therefore, in the present study, we confirmed an increased ER stress activation in the ileal
mucosa of CD patients. Bogaert et al. evaluated ileal and colonic samples from colonoscopy
examination of CD patients, and they verified ER stress activation only in the colonic mucosa
[40]. In our study we used ileal mucosa from surgical specimens of patients who present a
severe form of the disease, where the sensibility to detect ER stress activation may be broadly
favored. Moreover, we evaluated the ER stress activation and the UPR branches in the MAT of
CD patients. Studies of MAT in CD are quite recent and have increasingly attracted the inter-
est of the scientific community mainly due to the discovery that it can be considered a single
organ with its own function, physiology and presentation [41,42]. This is an exploratory obser-
vational study and the reduced sample size is one of the limitations we encountered, so follow-
up studies with a larger cohort are in order to confirm our findings. Another limitation is the
restricted age match of the patients: CD disease usually affects young adults, while the diseases
or symptoms that lead control individuals to be submitted to a colonoscopy examination or
surgery occur later in life.
In summary, for the first time in the literature, we characterized chaperone modulation in
MAT of CD patients, with no UPR branch activated. Although this is a descriptive study with
a small sample size, conducting research with human subjects brings a contribution to the
field that should not be underestimated. Thus, we demonstrated tissue-specific differences in
the activation of the pro-inflammatory ER stress mechanism in CD patients, which may be an
attractive target for drug development in this field.
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S1 Fig. Ponceau-S staining of the Western blot membranes used as loading controls. Pon-
ceau S staining was applied to determine the loading control and protein transfer efficiency in
Western blot analysis of sXBP1, ATF6, p-eIF2α and eIF2α expressions in intestinal mucosa as
presented in Figs 1, 2 and 3. CD = Crohn’s disease; CTR = control.
(PDF)
S2 Fig. Structural histological analysis of intestinal mucosa and mesenteric adipose tissue
(MAT) of Crohn’s disease patients. Haematoxylin and Eosin (H&E) staining was performed
on paraffin-embedded slides from intestinal mucosa and MAT of Crohn’s disease (CD)
patients and controls (CTR); nuclear counterstaining: Mayer’s haematoxylin. Original magni-
fication 200X (A). Immunohistochemical analysis of CD45 was performed on paraffin-embed-
ded slides from intestinal mucosa of CD and CTR groups to show the immune cell infiltration.
Original magnification 100X (B).
(PDF)
S3 Fig. DEFA5 gene expression in the intestinal mucosa of Crohn’s disease patients. mRNA
levels (qRT-PCR) of DEFA5 gene was investigated in the intestinal mucosa of CD patients
(CD group) compared to control group (CTR group). �p< 0.05 and ��p< 0.01 are is consid-
ered statistically significant versus control group. AU: arbitrary unit.
(PDF)
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S1 Table. Statistical analyses. The results are reported as median with interquartile range. To
check for distributional adequacy, the Kolmogorov-Smirnov test (Chakravart, Laha, and Roy,
1967) was used to investigate if the data follow normal distribution or Gaussian distribution
(p>0.1). All data were analyzed using the non-parametric Mann-Whitney Test. In the follow-
ing table we show the values of U, z-score and p. �p<0.05 and ��p<0.01 is the level of signifi-
cance.
(PDF)
S1 Appendix. Electrophoretic gels and blots—Compliance with the digital image.
(PDF)
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25. Adolph TE, Tomczak MF, Niederreiter L, Ko HJ, Böck J, Martinez-Naves E, et al. Paneth cells as a site
of origin for intestinal inflammation. Nature. 2013; 14: 503(7475):272–6. https://doi.org/10.1038/
nature12599 PMID: 24089213
26. Van Der Sloot KWJ, Joshi AD, Bellavance DR, Gilpin KK, Stewart KO, Lochhead P, et al. Visceral adi-
posity, genetic susceptibility, and risk of complications among individuals with Crohn’s disease. Inflamm
Bowel Dis. 2017; 23:82–88. https://doi.org/10.1097/MIB.0000000000000978 PMID: 27893544
27. Bettigole SE, Glimcher LH. Endoplasmic Reticulum Stress in Immunity. Annu Rev Immunol. 2015;
33:107–138. https://doi.org/10.1146/annurev-immunol-032414-112116 PMID: 25493331
28. Pott J, Maloy KJ. Epithelial autophagy controls chronic colitis by reducing TNF-induced apoptosis.
Autophagy. 2018; 8627:1–2. https://doi.org/10.1080/15548627.2018.1450021
29. Jiang H, Wek SA, McGrath BC, Scheuner D, Kaufman RJ, Cavener DR, et al. Phosphorylation of the
alpha subunit of eukaryotic initiation factor 2 is required for activation of NF-kappaB in response to
diverse cellular stresses. Mol Cell Biol. 2003; 23:5651–63. https://doi.org/10.1128/MCB.23.16.5651-
5663.2003 PMID: 12897138
30. Zeiger W, Ito D, Swetlik C, Oh-hora M, Villereal ML, Thinakaran G. Stanniocalcin 2 Is a Negative Mod-
ulator of Store-Operated Calcium Entry. Mol Cell Biol. 2011; 31:3710–3722. https://doi.org/10.1128/
MCB.05140-11 PMID: 21746875
31. Fazio EN, DiMattia GE, Chadi SA, Kernohan KD, Pin CL. Stanniocalcin 2 alters PERK signalling and
reduces cellular injury during cerulein induced pancreatitis in mice. BMC Cell Biol. 2011; 5(12):17.
https://doi.org/10.1186/1471-2121-12-17
32. Ito D, Walker JR, Thompson CS, Moroz I, Lin W, Veselits ML, et al. Characterization of stanniocalcin 2,
a novel target of the mammalian unfolded protein response with cytoprotective properties. Mol Cell Biol.
2004; 24:9456–9469. https://doi.org/10.1128/MCB.24.21.9456-9469.2004 PMID: 15485913
33. Roobol A, Roobol J, Bastide A, Knight JR, Willis AE, Smales CM. p58 IPK is an inhibitor of the eIF2α
kinase GCN2 and its localization and expression underpin protein synthesis and ER processing capac-
ity. Biochem J. 2015; 465:213–225. https://doi.org/10.1042/BJ20140852 PMID: 25329545
34. Petrova K, Oyadomari S, Hendershot LM, Ron D. Regulated association of misfolded endoplasmic
reticulum lumenal proteins with P58/DNAJc3. EMBO J. 2008; 27:2862–2872. https://doi.org/10.1038/
emboj.2008.199 PMID: 18923430
35. Ni M, Zhang Y, Lee AS. Beyond the endoplasmic reticulum: atypical GRP78 in cell viability, signalling
and therapeutic targeting. Biochem J. 2011; 434:181–188. https://doi.org/10.1042/BJ20101569 PMID:
21309747
36. Lee AS. Glucose-regulated proteins in cancer: Molecular mechanisms and therapeutic potential. Nat
Rev Cancer. 2014; 14:263–276. https://doi.org/10.1038/nrc3701 PMID: 24658275
37. Lewy TG, Grabowski JM, Bloom ME. BiP: Master regulator of the unfolded protein response and crucial
factor in flavivirus biology. Yale J Biol Med. 2017; 90:291–300. PMID: 28656015
38. Maruri-Avidal L, Lopez S, Arias CF. Endoplasmic Reticulum Chaperones Are Involved in the Morpho-
genesis of Rotavirus Infectious Particles J Virol. 2008; 82:5368–5380. https://doi.org/10.1128/JVI.
02751-07 PMID: 18385250
39. Mimura N, Hamada H, Kashio M, Jin H, Toyama Y, Kimura K, et al. Aberrant quality control in the endo-
plasmic reticulum impairs the biosynthesis of pulmonary surfactant in mice expressing mutant BiP. Cell
Death Differ. 2007; 14:1475–1485. https://doi.org/10.1038/sj.cdd.4402151 PMID: 17464327
40. Bogaert S, De Vos M, Olievier K, Peeters H, Elewaut D, Lambrecht B, et al. Involvement of endoplasmic
reticulum stress in inflammatory bowel disease: A different implication for colonic and ileal disease?
PLoS One. 6 2011; 6(10):e25589. https://doi.org/10.1371/journal.pone.0025589 PMID: 22028783
41. Coffey JC, O’Leary DP. The mesentery: structure, function, and role in disease. Lancet Gastroenterol
Hepatol. 2016; 1:238–247. https://doi.org/10.1016/S2468-1253(16)30026-7 PMID: 28404096
42. Mao R, Kurada S, Gordon IO, Baker ME, Gandhi N, McDonald C, et al. The Mesenteric Fat and Intesti-
nal Muscle Interface: Creeping Fat Influencing Stricture Formation in Crohn’s Disease. Inflamm Bowel
Dis. 2019; 21: 25(3):421–426. https://doi.org/10.1093/ibd/izy331 PMID: 30346528
ER stress activation in Crohn’s disease patients
PLOS ONE | https://doi.org/10.1371/journal.pone.0223105 September 26, 2019 19 / 19
